The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to ...
The upcoming patent expiry for Ozempic in India is set to dramatically lower the cost of semaglutide, making this once-premium diabetes and weight-loss drug accessible to more patients. This shift ...
India’s market for anti-obesity medicines is expected to undergo a significant shift in 2026, with prices of leading weight-loss injections likely to fall sharply. Industry estimates indicate that ...
A provisional patent application is a U.S. filing that can lock in an early priority date and let you mark your invention ...
A claim on the much-scrutinised university filing more patents than IITs combined has caught people's attention.
In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
xPy: Everspin Technologies’ brand for high-reliability, advanced STT-MRAM product lines designed for use in harsh ...
The texts, calls and WhatsApp messages never stop. "Point me in the direction of what dollar amount you need, and we'll get it priced out and funded today!" It's Bella, it's Jake, it's Zevi — ...
Graphic Packaging Holding Company (GPK) 47th Annual Raymond James Institutional Investor Conference March 4, 2026 9:50 AM ESTCompany ...
The market for weight-loss drugs is booming - but the pioneer in the field is shedding profits and share value, writes Adam Maguire ...
Q4 2025 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsMonica GouldSanjeev Aggarwal - President, CEO ...
The Paterson Museum in Paterson, New Jersey is exactly that kind of revelation, packed with more surprises than your grandmother’s attic and infinitely more organized. Let’s be honest, when someone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results